CSW Industrials (CSW) CEO reports 1,000-share sale and 967-share gift of stock
Rhea-AI Filing Summary
CSW Industrials, Inc. director and Chairman, President & CEO Joseph B. Armes reported recent insider stock transactions. On 12/15/2025 he sold 1,000 shares of common stock at a weighted average price of $317.4 under a Rule 10b5-1 trading plan, leaving 64,493 shares held directly.
On 12/16/2025 he made a bona fide gift of 967 shares to the Armes Family Foundation at $0, after which he held 63,526 shares directly and 3,219 shares indirectly through an ESOP. He also reports performance rights covering 8,004, 8,236, 12,422 and 18,372 shares and 19,685 restricted stock units, each representing a contingent right to receive one share of common stock subject to specified performance and service-based vesting conditions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 967 | $0.00 | -- |
| Sale | Common Stock | 1,000 | $317.40 | $317K |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $315.57 to $321.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Represents shares that were transferred by bona fide gift to the Armes Family Foundation, a family charitable foundation in which the reporting person has no pecuniary interest. Following the gift, the reporting person disclaims beneficial ownership of the securities held by the foundation. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023, and ending on March 31, 2026, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles ending on each of March 31, 2026 and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
FAQ
What insider stock transactions did CSW (CSW Industrials, Inc.) report for Joseph B. Armes?
Joseph B. Armes reported selling 1,000 shares of CSW common stock on 12/15/2025 and making a bona fide gift of 967 shares on 12/16/2025 to the Armes Family Foundation.
What is the Rule 10b5-1 trading plan referenced in the CSW insider filing?
The sale on 12/15/2025 was effected pursuant to a Rule 10b5-1 trading plan that Joseph B. Armes established on September 12, 2024, as disclosed in the footnotes.
What performance-based equity awards does the CSW CEO hold?
He reports performance rights linked to 8,004, 8,236, 12,422 and 18,372 shares of common stock. These vest between 0% and 200% over defined performance cycles based on relative total shareholder return versus the Russell 2000 Index and may be settled in cash or stock at the issuer's discretion.
What are the vesting conditions for the CSW restricted stock units held by the CEO?
The 19,685 restricted stock units each represent a contingent right to one CSW share. 40% vest upon the successful recruitment and hiring of a successor Chief Executive Officer, and the remaining 60% vest upon the successor CEO’s successful first employment anniversary.